FDA approves flu vaccine for coming season

August 14, 2012
FDA approves flu vaccine for coming season
Two of the three strains picked weren't in last year's shot, experts note.

(HealthDay) -- The formulation for the vaccine that will help protect against the flu this coming season was approved by the U.S. Food and Drug Administration on Monday.

"The best way to prevent influenza is by getting vaccinated each year," Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research, said in a statement. "It is especially important to get vaccinated this year because two of the three used in this season's influenza vaccines differ from the strains included in last year's vaccines."

Experts from the FDA, the U.S. Centers for Disease Control and Prevention and the , along with other , study global flu infection patterns to try to predict which strains of the virus are most likely to make people ill in the coming . Sometimes there is a mismatch between the strains in the vaccine and the strains that wind up infecting most people each season, but officials noted that even then the vaccine can lessen the severity of illnesses.

Six vaccine makers are licensed to provide the in the United States, and the 2012-2013 vaccine will include the following strains: A/California/7/2009 (H1N1)-like virus; A/Victoria/361/2011 (H3N2)-like virus; and B/Wisconsin/1/2012-like virus. The H1N1 virus is the same as the one included in last year's vaccine, while the other two differ from the strains used in the 2011-2012 vaccine, according to an FDA news release.

Between 5 percent and 20 percent of the U.S. population develops influenza each year, resulting in more than 200,000 hospitalizations from related complications. Influenza seasons can vary widely, with annual influenza-related deaths ranging from a low of about 3,000 to a high of about 49,000 people in the United States, the news release stated. The CDC recommends that everyone 6 months of age and older receive an annual .

The companies producing the 2012-2013 flu vaccines and the brand names of the vaccines are:

  • Afluria, manufactured by CSL Ltd.
  • Fluarix, manufactured by GlaxoSmithKline Biologicals
  • FluLaval, manufactured by ID Biomedical Corp.
  • FluMist, manufactured by MedImmune Vaccines Inc.
  • Fluvirin, manufactured by Novartis Vaccines and Diagnostics Ltd.
  • Fluzone, Fluzone High-Dose and Fluzone Intradermal, manufactured by Sanofi Pasteur

Explore further: FDA approves first 4-in-1 flu vaccine

More information: To prepare for the coming flu season, go to the U.S. Centers for Disease Control and Prevention.

Related Stories

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Four works better than three: An enhanced flu vaccine does the trick

April 4, 2012
An intranasal vaccine that includes four weakened strains of influenza could do a better job in protecting children from the flu than current vaccines, Saint Louis University research shows.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Tangent2
not rated yet Aug 14, 2012
For anyone interested in reading up on what exactly doctors know/need to know about vaccines that they push, take a look here at this revealing article:

http://fathernatu...#pid4785

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.